Northwest & Ethical Investments’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-12,014
Closed -$1.84M 438
2021
Q1
$1.84M Sell
12,014
-148
-1% -$20.1K 0.06% 276
2020
Q4
$1.53M Hold
12,162
0.06% 286
2020
Q3
$1.23M Buy
12,162
+2,350
+24% +$240K 0.05% 288
2020
Q2
$955K Buy
9,812
+1,628
+20% +$151K 0.05% 308
2020
Q1
$680K Buy
8,184
+1,939
+31% +$189K 0.04% 321
2019
Q4
$694K Buy
+6,245
New +$642K 0.03% 340

Other funds holding PRAH

Northwest & Ethical Investments's PRAH Position: Q2 2021 in Review

Northwest & Ethical Investments sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 12,014 shares — an estimated $1.84M sold.

Northwest & Ethical Investments first reported a position in PRAH in Q4 2019 and held it in 6 quarters. The position peaked at $1.84M in Q1 2021. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Northwest & Ethical Investments reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Northwest & Ethical Investments sold 12,014 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $1.84M.
  • Northwest & Ethical Investments first reported a position in PRA Health Sciences, Inc. in Q4 2019 and held it in 6 quarters.
  • Northwest & Ethical Investments's PRA Health Sciences, Inc. position peaked at $1.84M in Q1 2021.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Northwest & Ethical Investments's 13F filing for Q2 2021, filed 9 Jul 2025.